|
|
Volumn 52, Issue 5, 2001, Pages 529-538
|
|
Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROSTANE DERIVATIVE;
ANTIINFLAMMATORY AGENT;
BUDESONIDE;
FLUTICASONE;
HYDROCORTISONE;
ADULT;
AREA UNDER THE CURVE;
ARTICLE;
ASTHMA;
BIOLOGICAL MODEL;
BLOOD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
FEMALE;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG;
MALE;
METABOLISM;
MIDDLE AGED;
PEAK EXPIRATORY FLOW;
RANDOMIZED CONTROLLED TRIAL;
ADMINISTRATION, INHALATION;
ADULT;
ANDROSTADIENES;
ANTI-INFLAMMATORY AGENTS;
AREA UNDER CURVE;
ASTHMA;
BUDESONIDE;
CROSS-OVER STUDIES;
FEMALE;
HUMANS;
HYDROCORTISONE;
INJECTIONS, INTRAVENOUS;
LUNG;
MALE;
MIDDLE AGED;
MODELS, BIOLOGICAL;
PEAK EXPIRATORY FLOW RATE;
|
|
EID: 0035513523
PISSN: 03065251
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0306-5251.2001.01493.x Document Type: Article |
|
Times cited : (151)
|
|
References (0)
|
